DelveInsight
DelveInsight's primary conduit for delivering intelligent information to professionals in both the business and healthcare sectors is through its meticulously crafted analytical and strategic reports. Presently, DelveInsight boasts a diverse portfolio encompassing over 3,000 Marketed and Pipeline Reports. These reports are thoughtfully categorized based on parameters such as indication, mechanism of actions, drugs, global API manufacturers, and specialized reports focusing on pivotal areas such as Onco-Immunology, Orphan Diseases, Biologics & Biosimilars, Gene Therapy, Stem Cells Therapy, and other emerging domains. This robust platform has become the go-to resource for numerous enterprises seeking to transform and redefine their business strategies.
DelveInsight's offerings extend beyond reports to encompass Consulting Projects and Competitive Intelligence services, catering to the multifaceted needs of its clientele. Moreover, the organization is dedicated to providing tailor-made research services that align with the specific interests and requirements of its clients. DelveInsight's commitment to excellence and innovation positions it as a trusted partner in the areas of business strategy and market research.
View recent articles by this publisher on our blog:
The Power of Digital Therapeutics in Mental Health
Anti-VEGF Therapies: Forever Market Rulers of Wet-AMD Treatment?
Additional articles from this publisher
6,496 Reports from DelveInsight
-
Postmenopausal osteoporosis - Pipeline Insight, 2023
Postmenopausal osteoporosis - Pipeline Insight, 2023 DelveInsight’s, “Postmenopausal osteoporosis - Pipeline Insight, 2023,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Postmenopausal osteoporosis pipeline landscape. It covers the pipeline drug profiles, incl ... Read More
-
Anti-CD38 antibody- Pipeline Insight, 2023
Anti-CD38 antibody- Pipeline Insight, 2023 DelveInsight’s, “Anti-CD38 antibody- Pipeline Insight, 2023” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anti-CD38 antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More
-
Antibody Drug Conjugate- Competitive landscape, 2023
Antibody Drug Conjugate- Competitive landscape, 2023 DelveInsight’s, “Antibody Drug Conjugate- Competitive landscape, 2023,” report provides comprehensive insights about 180+ companies and 290+ drugs in Antibody Drug Conjugate Competitive landscape. It covers the therapeutics assessment by product t ... Read More
-
Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032
Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032 Key Highlights NSCLC market size has seen a revolutionary change in the last decade owing to the increase in incident case of NSCLC, continuous uptake of approved therapies mainly immune checkpoint inhibit ... Read More
-
Metastatic HR+/HER2− Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032
Metastatic HR+/HER2− Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032 Key Highlights Breast cancer is a genetically and clinically heterogeneous disease with multiple subtypes. The HR+/HER2- subtype is the most common of all the breast cancer subtypes. The total market size in ... Read More
-
Pozelimab Emerging Drug Insight and Market Forecast − 2032
Pozelimab Emerging Drug Insight and Market Forecast − 2032 “Pozelimab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about pozelimab for paroxysmal nocturnal hemoglobinuria (PNH) in the seven major markets. A detailed picture of the pozelimab for PNH in the ... Read More
-
PULMOZYME Drug Insight and Market Forecast − 2032
PULMOZYME Drug Insight and Market Forecast − 2032 “PULMOZYME Drug Insight and Market Forecast – 2032” report provides comprehensive insights about PULMOZYME for Cystic Fibrosis in the six major markets. A detailed picture of the PULMOZYME for cystic fibrosis in the 7MM, i.e., the United States, EU4 ... Read More
-
CAR-T Therapy- Pipeline Insight, 2023
CAR-T Therapy- Pipeline Insight, 2023 DelveInsight’s, “CAR-T Therapy- Pipeline Insight, 2023” report provides comprehensive insights about 200+ companies and 252+ pipeline drugs in CAR-T Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage produc ... Read More
-
EMPAVELI Drug Insight and Market Forecast − 2032
EMPAVELI Drug Insight and Market Forecast − 2032 “EMPAVELI Drug Insight and Market Forecast – 2032” report provides comprehensive insights about EMPAVELI for paroxysmal nocturnal hemoglobinuria (PNH) in the seven major markets. A detailed picture of the EMPAVELI for PNH in the 7MM, i.e., the United ... Read More
-
VXA-A1.1 Emerging Drug Insight and Market Forecast − 2032
VXA-A1.1 Emerging Drug Insight and Market Forecast − 2032 “VXA-A1.1 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VXA-A1.1 for seasonal influenza in the seven major markets. A detailed picture of the VXA-A1.1 for seasonal influenza in the 7MM, i.e., t ... Read More
-
mRNA-1010 Emerging Drug Insight and Market Forecast − 2032
mRNA-1010 Emerging Drug Insight and Market Forecast − 2032 “mRNA-1010 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about mRNA-1010 for seasonal influenza in the seven major markets. A detailed picture of the mRNA-1010 for seasonal influenza in the 7MM, i.e ... Read More
-
FLUARIX QUADRIVALENT Drug Insight and Market Forecast − 2032
FLUARIX QUADRIVALENT Drug Insight and Market Forecast − 2032 “FLUARIX QUADRIVALENT Drug Insight and Market Forecast – 2032” report provides comprehensive insights about FLUARIX QUADRIVALENT for seasonal influenza in the six major markets. A detailed picture of the FLUARIX QUADRIVALENT for seasonal i ... Read More
-
IMFINZI Emerging Drug Insight and Market Forecast − 2032
IMFINZI Emerging Drug Insight and Market Forecast − 2032 “IMFINZI Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about IMFINZI for malignant pleural mesothelioma (MPM) in the seven major markets. A detailed picture of the IMFINZI for MPM in the 7MM, i.e., th ... Read More
-
APT-1011 Emerging Drug Insight and Market Forecast − 2032
APT-1011 Emerging Drug Insight and Market Forecast − 2032 “APT-1011 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about APT-1011 for eosinophilic esophagitis (EoE) in the seven major markets. A detailed picture of the APT-1011 for EoE in the 7MM, i.e., the ... Read More
-
DNX-2401 Emerging Drug Insight and Market Forecast − 2032
DNX-2401 Emerging Drug Insight and Market Forecast − 2032 “DNX-2401 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about DNX-2401 for glioblastoma multiforme (GBM) in the seven major markets. A detailed picture of the DNX-2401 for GBM in the 7MM, i.e., the U ... Read More
-
Lerapolturev + Pembrolizumab Emerging Drug Insight and Market Forecast − 2032
Lerapolturev + Pembrolizumab Emerging Drug Insight and Market Forecast − 2032 “Lerapolturev + Pembrolizumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about lerapolturev + pembrolizumab for glioblastoma multiforme (GBM) in the seven major markets. A deta ... Read More
-
Cyclin-Dependent Kinase Inhibitor- Pipeline Insight, 2023
Cyclin-Dependent Kinase Inhibitor- Pipeline Insight, 2023 DelveInsight’s, “Cyclin-Dependent Kinase Inhibitor- Pipeline Insight, 2023” report provides comprehensive insights about 45+ companies and 52+ pipeline drugs in Cyclin-Dependent Kinase Inhibitor pipeline landscape. It covers the pipeline drug ... Read More
-
Primary Biliary Cholangitis - Pipeline Insight, 2023
Primary Biliary Cholangitis - Pipeline Insight, 2023 DelveInsight’s, “Primary Biliary Cholangitis - Pipeline Insight, 2023,” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Primary Biliary Cholangitis pipeline landscape. It covers the pipeline drug profiles, incl ... Read More
-
Niemann-Pick Disease Type C - Market Insight, Epidemiology And Market Forecast - 2032
Niemann-Pick Disease Type C - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights In 2022, the market size of Niemann–Pick Disease Type C (NPC) was the highest in the US among the 7MM, accounting for approximately USD 9 million, expected to increase by 2032. There are 787 diagnose ... Read More
-
Danicopan Emerging Drug Insight and Market Forecast − 2032
Danicopan Emerging Drug Insight and Market Forecast − 2032 “Danicopan Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about danicopan for paroxysmal nocturnal hemoglobinuria (PNH) in the seven major markets. A detailed picture of the danicopan for PNH in the ... Read More
-
Bertilimumab Emerging Drug Insight and Market Forecast − 2032
Bertilimumab Emerging Drug Insight and Market Forecast − 2032 “Bertilimumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about bertilimumab for bullous pemphigoid in the seven major markets. A detailed picture of the bertilimumab for bullous pemphigoid in ... Read More
-
FLU-v Emerging Drug Insight and Market Forecast − 2032
FLU-v Emerging Drug Insight and Market Forecast − 2032 “FLU-v Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about FLU-v for seasonal influenza in the seven major markets. A detailed picture of the FLU-v for seasonal influenza in the 7MM, i.e., the United St ... Read More
-
SAB-176 Emerging Drug Insight and Market Forecast − 2032
SAB-176 Emerging Drug Insight and Market Forecast − 2032 “SAB-176 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about SAB-176 for seasonal influenza in the seven major markets. A detailed picture of the SAB-176 for seasonal influenza in the 7MM, i.e., the U ... Read More
-
MesoPher Drug Insight and Market Forecast − 2032
MesoPher Drug Insight and Market Forecast − 2032 “MesoPher Drug Insight and Market Forecast – 2032” report provides comprehensive insights about MesoPher for malignant pleural mesothelioma (MPM) in the seven major markets. A detailed picture of the MesoPher for MPM in the 7MM, i.e., the United State ... Read More
-
JORVEZA Drug Insight and Market Forecast − 2032
JORVEZA Drug Insight and Market Forecast − 2032 “JORVEZA Drug Insight and Market Forecast – 2032” report provides comprehensive insights about JORVEZA for Eosinophilic esophagitis (EoE) in the seven major markets. A detailed picture of the JORVEZA for EoE in the 5MM, i.e., EU4 (Germany, France, Ital ... Read More
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook